uric acid has been researched along with 3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirschhorn, WL; Meidl, E; Morgan, JM; Piraino, AJ; Saris, SD; Schaffer, AV | 1 |
1 trial(s) available for uric acid and 3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid
| Article | Year |
|---|---|
Uricosuric effect of CGS-12970, a new thromboxane synthase inhibitor.
Topics: Adolescent; Adult; Animals; Cattle; Creatinine; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Male; Middle Aged; Pyridines; Reference Values; Single-Blind Method; Thromboxane-A Synthase; Uric Acid; Uricosuric Agents; Xanthine Oxidase | 1993 |